BioPharma Innovation — Mini-MBA™
Rutgers Business School
Rutgers Business School
Coursalytics is an independent platform to find, compare, and book executive courses. Coursalytics is not endorsed by, sponsored by, or otherwise affiliated with any business school or university.
Full disclaimer.Who should attend
The Mini-MBA™: BioPharma Innovation is for:
- Scientists or clinicians who need a better understanding of the business operations of the Pharmaceutical and Biotech industries
- Managers who would like a broader picture of the environment in which new drugs and devices are developed
- Leaders who have been promoted into commercial roles from functional, medical, chemical or engineering backgrounds
- Regulatory and compliance personnel who seek updated information about today's legal and regulatory realities
- Marketing and sales professoinals who require a thorough understanding of how new drugs and devices are developed and brought to market
- Anybody seeking to kickstart a career in Pharma or Biotech
- Students pursuing advanced study and contemplating careers in the bioscience sector (MD, PhD)
About the course
Life sciences professionals, whether they spend their day-to-day in the lab or behind a desk, need to maintain excellence in their own expertise as well as understand the role they play in their organization’s overall business and operational environments. Definitions of success are shifting, impacted by scientific advancement, ongoing regulatory developments, and the globalization of supply and distribution.
The Mini-MBA in BioPharma Innovation teaches life sciences experts key business management theory and methodology that will broaden their perspective. This course provides a better understanding of how biopharma companies plan for, and profit from, constant innovation.
Program benefits
- Learn how to bridge the space between scientific success and corporate goals from industry experts with real-world experience.
- Gain industry-wide perspective on how these concepts impact different organizations; yet receive practical application beyond theoretical study. Enjoy interactive learning that encourages doing, not just listening.
- Learn in a rigorous university environment and earn a program certificate as well as academic credits that can be applied toward future education goals.
Program Outcomes
- Speak with confidence about business strategy outside the lab. At the same time, those who are not scientists will have a better appreciation of the broad landscape of this industry that includes pharmaceuticals, medical devices and other biotechnology.
- Master the language of business management in order to more effectively communicate to non-clinicians across the organization. Expand your contributions beyond R&D of the business to analysis of strategy and ROI.
- Become a valued participant in cross-functional projects and strategic teams, which will broaden your network and diversify your career opportunities.
Curriculum
Featuring 10 modules (each covered in 3.5 hours), this program empowers biotechnology and pharmaceutical professionals to use business strategies and methods to complement achievement in scientific study, with multidisciplinary contributions and thought leadership.
Topics include:
- Modeling the Return in Investment in Research and Development. Learn the financial models and methods that corporate decision makers apply, including discounted cash flow models, net present value, and internal rates of return.
- Strategic Alliances and Acquisitions. Analyze the role of partnering and mergers from a strategic perspective, including the financial and managerial challenges incumbent in the uncertainties specific to drug and biotech discovery and development.
- Innovation in the Pharmaceutical and Biotechnology Industries. Learn how the psychology of decision-making, organizational structure, and corporate culture influence stakeholders’ decisions, and its impact on R&D funding.
Experts
Gary Branning
Mr. Branning is President of Managed Market Resources (MMR), a healthcare consulting and medical communications company, offering the pharmaceutical and biotechnology industry innovative solutions for the complex healthcare market, responsible for strategic consulting, new product development, bu...
Ron Guido
Ron Guido is an independent consultant in the health care industry specializing in business development, marketing and supply chain management. Ron has 36 years experience with Johnson & Johnson. He has held vice president level positions in the areas of operations, sales, product marketing,...
Amy Porter
Amy L. Porter has thirty years experience in healthcare. Her influence in building both internal and external alliances has led to enhanced communications and effectiveness across functional lines in both academic and industrial settings. Previously, Amy was Senior Director of Licensing at Pfize...
Gene Slowinski
Gene has held management positions at AT&T Bell Laboratories, Bellcore, and Novartis Corporation. Dr. Slowinski has conducted research on the economic development opportunities of strategic alliances, demanufacturing, and the Internet. An author and lecturer, Gene has presented his work to Th...
Steven Director
Steve Director returned to a full time faculty role after completing a six year term as Associate Dean of the Rutgers School of Management and Labor Relations at Rutgers University. He teaches graduate level course in Financial Analysis on the Rutgers campus and has taught executives from numerou...
Videos and materials
BioPharma Innovation — Mini-MBA™ at Rutgers Business School
Because of COVID-19, many providers are cancelling or postponing in-person programs or providing online participation options.
We are happy to help you find a suitable online alternative.